[Atherosclerosis and vascular calcification in hemodialysis patients]

Naohisa Hirasaka1, Xiang-Ming Liang, Masatoshi Mune

  • 1Department of Internal Medicine III, Wakayama Medical University.

Clinical Calcium
|December 4, 2004
PubMed

Insights

Cardiovascular disease is a major concern for hemodialysis patients, with higher mortality rates due to atherosclerosis and vascular calcification. Oxidative stress and hyperphosphatemia are key contributors, but Vitamin E and phosphate control may offer protection.

Area of Science:

  • Nephrology and Cardiovascular Medicine
  • Biochemistry and Oxidative Stress

Context:

  • Cardiovascular disease (CVD) is the leading cause of mortality in patients undergoing hemodialysis, with rates five to twenty times higher than the general population.
  • Atherosclerosis and vascular calcification are prevalent complications, driven by traditional risk factors (e.g., abnormal lipid metabolism) and uremia-specific factors (e.g., oxidative stress, hyperphosphatemia).

Purpose:

  • To elucidate the mechanisms linking oxidative stress and hyperphosphatemia to accelerated atherosclerosis and vascular calcification in hemodialysis patients.
  • To highlight the role of Matrix Gla Protein (MGP) in vascular calcification and the potential protective effects of Vitamin E and phosphate management.

Summary:

  • Oxidative stress in hemodialysis patients involves increased oxidant production and decreased antioxidant levels (Vitamins C and E), leading to modified LDL and promoting atherosclerosis.
  • Both oxidative stress and hyperphosphatemia contribute to vascular calcification, characterized by mineral deposition in the tunica media.
  • MGP knockout mice exhibit significant calcification, indicating MGP's inhibitory role. Vitamin E demonstrates protective effects against atherosclerosis and vascular calcification.

Impact:

  • Understanding these pathways is crucial for developing targeted interventions to reduce cardiovascular mortality in hemodialysis patients.
  • Therapeutic strategies focusing on antioxidant supplementation (Vitamin E) and strict hyperphosphatemia control are essential for mitigating vascular complications.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...